• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Lp(a) Genetic Patterns

Opinion
Video

Jaime Murillo, MD, explores genetic inheritance patterns of Lp(a) from childhood to adulthood, highlighting stability, factors affecting measurement, and awareness challenges among those in the health care community.

This is a video synopsis/summary of an Insights involving Michael D. Shapiro, DO, and Jaime Murillo, MD.

Murillo delves into the genetic inheritance patterns of lipoprotein(a) (Lp[a]), stressing its stable nature from childhood to adulthood, unlike fluctuating factors like sugar levels. Emphasizing its genetic determination, he highlights that stable conditions ensure consistent Lp(a) levels, reducing the need for frequent measurements. However, he notes the lack of awareness among health care providers and payers due to the asymptomatic nature of Lp(a) until an adverse event occurs.

Murillo identifies key factors contributing to this unawareness, including reactive health care practices and the absence of a known treatment for Lp(a). He proposes educational campaigns for both health care providers and individuals to understand the risks associated with Lp(a), stressing lifestyle changes’ potential in reducing cardiovascular risks by 75%. Furthermore, he advocates for constant guideline updates and awareness initiatives to standardize Lp(a) measurement as part of routine care, fostering partnerships between providers and patients to manage associated risks effectively.

Video synopsis is AI-generated and reviewed by AJMC® editorial staff.

Related Videos
Video 2 - "Payer Needs and Strategies for Evaluating and Covering PDTs"
Video 1 - "Differentiating PDTs from Wellness Apps and Evaluating Efficacy"
Video 4 - "Oral SERDs in Development for ER+/HER2- Metastatic Breast Cancer"
Video 3 - "The Role of Oral SERDs in ER+/HER2- Metastatic Breast Cancer"
"Integrating New PAH Therapies into Clinical Practice"
"Clinical Evidence for Emerging PAH Therapies"
Video 13 - "Individualized Therapy for Specific Infections Associated with Bronchiectasis"
Video 11 - "Social Burden and Goals of Therapy for Patients with Bronchiectasis"
Video 15 - "Ensuring Fair Cardiovascular Care for All: Concluding Perspectives on Disparities and Inclusion"
Video 11 - "Social Burden and Goals of Therapy for Patients with Bronchiectasis"
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.